title: Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types.
authors.affiliation: Cyclacel Ltd., 1 James Lindsay Place, Dundee DD1 5JJ, UK. sgreen@cyclacel.com
authors.forename: S R
authors.initials: SR
authors.lastname: Green
authors.forename: A K
authors.initials: AK
authors.lastname: Choudhary
authors.forename: I N
authors.initials: IN
authors.lastname: Fleming